Check out the stocks that will be in focus during trade today based on recent and latest news developments.
HCL Technologies and Google Cloud expanded partnership to deliver accelerated business intelligence platform.
ICICI Bank Board approved proposal to resume seeking approval from RBI for the appointment of Sandeep Batra as a wholetime director (designated as executive director) of the Bank, for a period of five years.
Suven Pharma Board sets record date for bonus issue at Sept.28. On Aug.17, board approved bonus issue of one share for every one share held in the company.
The meeting of the board of directors of HSIL is scheduled for September 21 to consider the proposal of buyback of the fully paid-up equity shares.
Aviation Stocks in focus as Airlines operators have sought government help to ask banks to defer loan repayments by six months, and not to classify such loans as non-performing, Civil Aviation Minister Hardeep Singh Puri said in written reply to parliament.
Also Read: OnePlus 8T teased on Amazon India, launch soon
Action Construction Equipment: ICRA assigned a long-term rating of AA- with a stable outlook to Rs395cr bank facilities of the company.
Genus Paper & Boards: SEBI imposed a penalty on three erstwhile promoters (including the company) of Genus Prime Infra for certain non-compliances of regulations.
GMR Infrastructure Promoter entity GMR Enterprises created a pledge on 3.75 crore equity shares of the company.
Dhanuka Agritech approved the proposal of buyback of shares worth up to Rs100cr and fixed September 28 as record for determining the entitlement of equity shareholders.
Puravankara Board approved issue of raising Rs70cr via NCDs.
Intellect Design Arena’s banking platform has gone live for Bank of Bahrain and Kuwait.
Crisil has upgraded long term rating outlook of bank loan facilities of Rs 750 crore of Deepak Nitrite from CRISIL AA- to CRISIL AA- with outlook changing from stable to positive.
Sanofi India’s Charles Billard resigned from the post of CFO with effect from Sept.30 to take up new role within Sanofi Group. He will continue to be the non-executive director of the company.
